Ontology highlight
ABSTRACT:
SUBMITTER: Gallagher EJ
PROVIDER: S-EPMC10831089 | biostudies-literature | 2024 Jan
REPOSITORIES: biostudies-literature
Gallagher Emily J EJ Moore Heather H Lacouture Mario E ME Dent Susan F SF Farooki Azeez A Goncalves Marcus D MD Isaacs Claudine C Johnston Abigail A Juric Dejan D Quandt Zoe Z Spring Laura L Berman Brian B Decker Melanie M Hortobagyi Gabriel N GN Kaffenberger Benjamin H BH Kwong Bernice Y BY Pluard Timothy T Rao Ruta R Schwartzberg Lee L Broder Michael S MS
NPJ breast cancer 20240131 1
Hyperglycemia and rash are expected but challenging adverse events of phosphatidylinositol-3-kinase inhibition (such as with alpelisib). Two modified Delphi panels were conducted to provide consensus recommendations for managing hyperglycemia and rash in patients taking alpelisib. Experts rated the appropriateness of interventions on a 1-to-9 scale; median scores and dispersion were used to classify the levels of agreement. Per the hyperglycemia panel, it is appropriate to start alpelisib in pat ...[more]